View All Reports Email Us

Health care mHealth Market Research Report- Global Forecast To 2022

  • ID: MRFR/HC/1284-CRR
  • |
  • November, 2016
  • |
  • Region: Global
  • |
  • 301 pages
  • |
  • Cooked Research Reports

mHealth Market Information, By Therapeutics(respiratory, mental and neurological disorders, fitness & lifestyle) By Application(monitoring, diagnosis & treatment, wellness & prevention) - Forecast to 2022

Study Objectives of the Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the mHealth market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide forecast revenue of the market segments and sub-segments with respect to the main geography and various regions globally.

  • To provide regional level analysis of the market with respect to the current market size and future prospective

  • To provide regional level analysis of the market for segments by therapeutics, by application and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global mHealth market.


MHealth market, by Region (%)



Intended Audience



  • MHealth companies

  • Hospitals and Dental Clinics

  • National Organizations & Government Organizations

  • Academic research institutes

  • Government institutes


Market Synopsis of MHealth Market:


Market Scenario:


The global mHealth market is one of the fastest growing industries, owing to the changing dynamics of the legal and regulatory workflow and the intense competitive rivalry among large number of public companies. Mobile health (mHealth) is also one of the most modernized trends in the healthcare industry that has shown tremendous progress in the last few years. This trend is observed due to the increasing growth of personal health devices, which can be easily worn or used with a smartphone or tablet. The various factors that influence the growth of mHealth market are patient’s involvement in personal healthcare, implementation of smartphones and wearable devices into healthcare industry, integration of wireless technologies with healthcare devices that are portable, benefits of Cost effectiveness and patients’ convenience and Increase in lifestyle diseases. Globally the market for mHealth is expected to grow at 36.5% CAGR (2016-2022).


 Key Finding



  • The mHealth global market is expected to reach $ 21.71Billion by 2022.

  • Americas holds the largest market share of 34% of mHealth market globally.

  • Europe market is expected to grow at a CAGR of 35.65%.

  • Monitoring application segment hold 61.8% market share of global mHealth market by application.


 Segments:                                                                                                                                        


mHealth market has been segmented on the basis of therapeutics which comprises of diabetes, respiratory, mental and neurological disorders, fitness & lifestyle therapeutics and others. Whereas on the basis of application the market is segmented into monitoring applications, diagnosis & treatment, education and awareness, healthcare management, wellness & prevention, remote data collection


Regional Analysis of mHealth Market:                                                                     


Globally Americas is the largest market for mHealth market. The large size of the market can be attributed due to increasing digital advancement in medical technology. Asia-Pacific is the second-largest for mHealth market. Europe mHealth market is expected to grow with a steady pace.


Key Players for mHealth Market:                                                                   


Some of the key players in this market are: Agamatrix, INC, Alivecor, INC, Apple, INC, Athenahealth INC, AT&T, INC, Biotelemetry INC. (CARDIONET), GE Healthcare, Google INC, Jawbone INC, Johnson & Johnson, Laboratory Corporation of America Holdings, Philips Healthcare and others.                        


North America


  • US

  • Canada


Europe


  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Europe


Asia


  • China

  • India

  • Japan

  • South Korea

  • Rest of Asia

  • Pacific


Latin America, Middle East & Africa

The report for mHealth market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions


 

   

 Table Of Content  


1    REPORT SCOPE

1.1    SCOPE OF THE STUDY

1.1.1    MOBILE HEALTH (MHEALTH): REPORT COVERAGE

1.1.2    XX RESEARCH METHODOLOGY

1.1.3    RESEARCH METHODOLOGY FOR THE GLOBAL MARKET STUDY

1.1.3.1    Geographical Analysis

1.1.3.2    Demand Side & Supply Side Analysis

1.1.3.3    Data Synthesis & Bridging

1.1.4    GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY

1.1.5    KEY DATA POINT SOURCES

1.1.5.1    Data Points taken from Secondary Sources

1.1.5.2    Data Points taken from Primary Sources

1.1.6    REPORT DESCRIPTION

2    EXECUTIVE SUMMARY

3    MARKET OVERVIEW


3.1    INTRODUCTION

3.2    MARKET DYNAMICS

3.2.1    MARKET DRIVERS

3.2.1.1    Patients Involvement in personal healthcare

3.2.1.2    Proliferation of Smartphones and wearable devices into healthcare

3.2.1.3    Integration of wireless technologies with portable healthcare devices

3.2.1.4    Introduction of connected healthcare solutions in the mHealth market

3.2.1.5    Benefits of Cost effectiveness and Patients’ Convenience

3.2.1.6    Increase in Lifestyle Disease

3.2.2    MARKET CHALLENGES

3.2.2.1    Low rate of literacy and language barriers in low- and middle-income countries (LMICs)

3.2.2.2    Invasion of Privacy

3.2.2.2.1    Security Breach Cases

3.2.2.2.2    Potential risk of Hardware or Software failure

3.2.2.2.3    Stringent Regulations and Standards

3.2.2.2.4    Lack of Awareness about the possible applications of mHealth

3.2.3    MARKET OPPORTUNITIES

3.2.3.1    Partnership: An entry mode

3.2.3.2    Introduction of mHealth in developing economies

4    INDUSTRY DYNAMICS

4.1    MHEALTH MARKET TIMELINE

4.2    VALUE CHAIN OF THE MHEALTH MARKET

4.2.1.1    Device Manufacturers

4.2.1.2    App Developers

4.2.1.3    Network providers/ Mobile operators

4.2.1.4    Healthcare providers and Pharmaceuticals

4.2.1.5    Patients

4.2.1.6    Consortiums, Certification, Regulations, & Standards

4.2.1.6.1    Introduction

4.2.1.6.2    Consortiums

4.2.1.6.3    Alliance/Associations

4.2.1.6.4    Regulatory Bodies

4.2.1.7    Food and Drug Administration (FDA)

4.2.1.8    Medical Device Regulation Act

4.2.1.9    Medical Mobile Application(MMA)

4.2.2    CERTIFICATION

4.2.3    MHEALTH DEVICE: PORTER’S FIVE FORCE ANALYSIS

4.2.4    BARGAINING POWER OF BUYER

4.2.5    BARGAINING POWER OF SUPPLIER

4.2.6    THREAT FROM SUBSTITUTE

4.2.7    THREAT FROM A NEW ENTRANT

4.2.8    INTENSITY OF COMPETITIVE RIVALRY

5    GLOBAL MHEALTH MARKET ECOSYSTEM

5.1    INTRODUCTION

5.1.1    MHEALTH DEVICES

5.1.2    MEDICAL DEVICES

5.1.2.1    SMBG monitor

5.1.2.1.1    SMBG Device Types& Uses

5.1.2.1.2    Diseases Managed by SMBG Device

5.1.2.1.3    Key players

5.1.2.2    Blood Pressure (BP) Monitor

5.1.2.2.1    BP Monitor Device Types & Uses

5.1.2.2.2    Diseases Managed by BP Monitor Device

5.1.2.2.3    Key players

5.1.2.2.4    Pulse Oximeter

5.1.2.2.5    Pulse Oximeter : Types & Uses

5.1.2.2.6    Diseases Managed by Pulse Oximeter Device

5.1.2.2.7    Key players

5.1.2.3    Cardiac Monitors

5.1.2.3.1    Diseases Managed by Cardiac Monitors

5.1.2.3.2    Disease Management Devices Types

5.1.2.3.3    Cardiac Monitor Uses

5.1.2.4    Key players

5.1.2.5    Other medical devices

5.1.2.5.1    Health and Fitness Devices

5.1.2.5.2    Hand Worn Products

5.1.2.5.2.1    Smart Watch

5.1.2.5.2.2    Wrist Wear

5.1.2.5.3    Key players

5.1.2.5.4    Head Worn Products

5.1.2.5.4.1    AR/VR HMD/HUD

5.1.2.5.4.2    Others

5.1.2.5.4.3    Body worn products

5.1.2.5.4.4    Smart Textile

5.1.2.5.4.5    Wearable Patch

5.1.2.5.4.6    Others

5.1.2.5.5    Non-Clinical applications

5.1.2.5.6    Clinical Application

5.1.2.6    Others Devices

5.1.2.6.1    Mobile telemedicine/tele-care devices

5.1.2.6.2    Home care devices

5.1.2.6.2.1    Vessyl

5.1.2.6.2.2    TAO

5.1.2.6.2.3    CubeSensors

5.1.2.6.2.4    Kolibree

5.1.2.6.2.5    TellSpec

5.1.2.6.2.6    Kinsa

5.1.2.6.2.7    Beddit

5.1.2.6.2.8    Wello iPhone Case

5.1.2.6.3    Key Participants

5.1.2.7    mHealth Services

5.1.3    MOBILE HEALTH APPS AND CONTENT SOLUTION

5.1.3.1    Software

5.1.3.2    Big data

5.1.3.3    Key Market Trends, Developments and Participants

5.1.3.3.1    Market Trends and Market Developments

5.1.3.3.2    Key Participants

5.1.4    NETWORK AND SERVICES/ MOBILE OPERATORS

5.1.4.1    Benefits of network & Services

5.1.4.2    Key Market Trends, Developments and Participants

5.1.4.2.1    Market Trends and Market Developments

5.1.4.2.2    Key Participants

5.1.5    HEALTHCARE AND PHARMACEUTICALS

5.1.5.1    Healthcare providers

5.1.5.2    Pharmaceuticals

5.1.5.2.1    Key Market Trends, Developments and Participants

5.1.5.2.1.1    Market Trends and Market Developments

5.1.5.2.1.2    Key Participants

6    GLOBAL MHEALTHMARKET – THERAPEUTICS

6.1    INTRODUCTION

6.1.1    GLOBAL MARKET STATISTICS

6.1.1.1    Cardiovascular Diseases

6.1.2    DEVICES

6.1.3    APPS

6.1.4    KEY PLAYERS

6.2    DIABETES

6.2.1    DEVICES

6.2.2    APPS

6.2.3    KEY PLAYERS

6.3    RESPIRATORY

6.3.1    DEVICES

6.3.2    APPS

6.3.3    KEY PLAYERS

6.4    MENTAL AND NEUROLOGICAL DISORDERS

6.4.1    DEVICES

6.4.2    APPS

6.4.3    KEY PLAYERS

6.5    FITNESS & LIFESTYLE THERAPEUTICS

6.5.1    DEVICES

6.5.2    APPS

6.5.3    KEY PLAYERS

6.6    OTHERS

7    GLOBAL MHEALTHMARKET – APPLICATION/ SOLUTION TYPE

7.1    INTRODUCTION

7.1.1    MONITORING APPLICATIONS

7.1.1.1    Key Participants

7.1.2    DIAGNOSIS & TREATMENT

7.1.2.1    Key Participants

7.1.3    EDUCATION AND AWARENESS

7.1.3.1    Key Participants

7.1.4    HEALTHCARE MANAGEMENT

7.1.5    WELLNESS & PREVENTION

7.1.6    OTHERS/ OTHER SERVICES AND APPLICATIONS MARKET

7.1.7    REMOTE DATA COLLECTION

7.1.7.1    Key Market Developments

8    GLOBAL MHEALTH MARKET–GEOGRAPHY

8.1    INTRODUCTION

8.1.1    MARKET STATISTICS

8.1.2    THE AMERICAS

8.1.3    NORTH AMERICA

8.1.3.1     U.S.

8.1.3.1.1    Key Market trends, Developments and Participants

8.1.3.1.1.1    Key Market Trends and Developments

8.1.3.1.1.2    Key Participants

8.1.3.2    Canada

8.1.3.2.1    Key Market Trend

8.1.3.2.2    Key players

8.1.3.3    South America

8.1.3.3.1    Constraints

8.1.3.3.2    Key Market Trends, Developments and Participants

8.1.3.3.2.1    Market Trends and Market Developments

8.1.3.3.2.2    Key Participants

8.1.4    ASIA-PACIFIC (APAC)

8.1.4.1    Key Drivers in APAC

8.1.4.1.1    Key Market Trends, Developments and Participants

8.1.4.1.1.1    Market Trends & Development

8.1.4.1.1.2    Key Participants

8.1.4.2    CHINA

8.1.4.3    JAPAN

8.1.4.4    AUSTRALIA

8.1.4.5    INDIA

8.1.5    EUROPE

8.1.5.1    Key Market Trends, Developments and Participants

8.1.5.2    The U.K.

8.1.5.3    Germany

8.1.5.4    Key Participants

8.1.6    REST OF THE WORLD (ROW)

8.1.6.1    Africa

8.1.6.1.1    Key Market Trends, Developments and Participants

8.1.6.1.1.1    Market Trends and Market Developments

8.1.6.1.2    Key Participants

8.1.7    MIDDLE EAST

8.1.7.1    Key Market Trends, Developments and Participants

8.1.7.1.1    Market Trends and Market Developments

8.1.7.1.2    Key Participants

9    KEY MARKET DEVELOPMENT AND STRATEGIES

9.1    INTRODUCTION

9.1.1    PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

9.1.2    MERGERS & ACQUISITIONS

9.1.3    PRODUCT DEVELOPMENT AND LAUNCH

9.1.4    BUSINESS EXPANSION/CONTRACTS

9.1.5    PATENTS, APPROVALS AND CERTIFICATIONS

9.1.6    OTHERS (EVENTS & RECOGNITIONS)

10    COMPANY PROFILES

10.1    AGAMATRIX, INC.

10.1.1    OVERVIEW

10.1.2    FINANCIALS

10.1.3    KEY DEVELOPMENTS

10.2    ALIVECOR, INC.

10.2.1    OVERVIEW

10.2.2    FINANCIALS

10.2.3    KEY DEVELOPMENTS

10.3    APPLE, INC.

10.3.1    OVERVIEW

10.3.2    FINANCIALS

10.3.2.1    Overall Financials

10.3.2.2    Financials By Segment

10.3.2.3    Financials By Region

10.3.2.4    Financial Summary

10.3.3    KEY DEVELOPMENT

10.4    ATHENAHEALTH INC.

10.4.1    OVERVIEW

10.4.2    FINANCIALS

10.4.2.1    Overall Financials

10.4.2.2    Financial by Segments

10.4.2.3    Financial Summary

10.4.3    KEY DEVELOPMENT

10.5    AT&T, INC.

10.5.1    OVERVIEW

10.5.2    FINANCIALS

10.5.2.1    Overall Financials

10.5.2.2    Financials By Segment

10.5.2.3    Financial Summary

10.5.3    KEY DEVELOPMENTS

10.6    BIOTELEMETRY, INC. (CARDIONET)

10.6.1    OVERVIEW

10.6.2    FINANCIALS

10.6.2.1    Overall Financials

10.6.2.2    Financials by Segment

10.6.2.3    Financial Summary

10.6.3    KEY DEVELOPMENTS

10.7    GE HEALTHCARE

10.7.1    OVERVIEW

10.7.2    FINANCIALS

10.7.2.1    Overall Financials

10.7.2.2    Financials by Segment

10.7.2.3    Financial Summary

10.7.3    KEY DEVELOPMENTS

10.8    GOOGLE INC.

10.8.1    OVERVIEW

10.8.2    FINANCIALS

10.8.2.1    Financial Summary

10.8.3    KEY DEVELOPMENTS

10.9    JAWBONE, INC.

10.9.1    OVERVIEW

10.9.2    FINANCIALS

10.9.3    KEY DEVELOPMENTS

10.1    JOHNSON & JOHNSON

10.10.1    OVERVIEW

10.10.2    FINANCIALS

10.10.2.1    Overall Financials

10.10.2.2    Net Revenue By Segment

10.10.2.3    Net revenue by Region

10.10.3    KEY DEVELOPMENTS

10.11    LABORATORY CORPORATION OF AMERICA HOLDINGS

10.11.1    OVERVIEW

10.11.2    FINANCIALS

10.11.2.1    Overall Financials

10.11.2.2    Financials by Segment

10.11.2.3    Financial Summary

10.11.3    KEY DEVELOPMENTS

10.12    MEDTRONIC PLC

10.12.1    OVERVIEW

10.12.2    FINANCIALS

10.12.2.1    Overall Financials

10.12.2.2    Financial Summary

10.12.3    KEY DEVELOPMENTS

10.13    NIKE INC.

10.13.1    OVERVIEW

10.13.2    FINANCIALS

10.13.2.1    Overall Financials

10.13.2.2    Financials by Segments

10.13.2.3    Financial Summary

10.13.3    KEY DEVELOPMENTS

10.14    PFIZER

10.14.1    OVERVIEW

10.14.2    FINANCIALS

10.14.2.1    Overall Financials

10.14.2.2    Financials by Segment

10.14.2.3    Financials By Region

10.14.2.4    FINANCIAL SUMMARY

10.14.3    KEY DEVELOPMENTS

10.15    PHILIPS HEALTHCARE

10.15.1    OVERVIEW

10.15.2    FINANCIALS

10.15.2.1    Overall Financials

10.15.2.2    Financials By Region

10.15.2.3    Financials By Segment

10.15.2.4    Financial Summary

10.15.3    KEY DEVELOPMENTS

10.16    QUALCOMM, INC.

10.16.1    OVERVIEW

10.16.2    FINANCIALS

10.16.2.1    Overall Financials

10.16.2.2    Financials By Segment

10.16.2.3    Financials By Region

10.16.2.4    Financial Summary

10.16.3    KEY DEVELOPMENTS

10.17    QUEST DIAGNOSTICS INC.

10.17.1    OVERVIEW

10.17.2    FINANCIALS

10.17.2.1    Overall Financials

10.17.2.2    Financials by Segment

10.17.2.3    Financial Summary

10.17.3    KEY DEVELOPMENTS

10.18    ROCHE HOLDING AG-BR

10.18.1    OVERVIEW

10.18.2    FINANCIALS

10.18.2.1    Overall Financials

10.18.2.2    Financials by Segment

10.18.2.3    Financial Summary

10.18.3    KEY DEVELOPMENTS

10.19    SAMSUNG ELECTRONICS CO. LTD.

10.19.1    OVERVIEW

10.19.2    FINANCIALS

10.19.2.1    Overall financials

10.19.2.2    Financial Summary

10.19.3    KEY DEVELOPMENTS

10.2    SANOFI PHARMA

10.20.1    OVERVIEW

10.20.2    FINANCIALS

10.20.2.1    Overall Financials

10.20.3    FINANCIALS BY SEGMENT

10.20.4    FINANCIAL SUMMARY

10.20.5    KEY DEVELOPMENTS

10.21    WITHINGS SAS

10.21.1    OVERVIEW

10.21.2    FINANCIALS

10.21.3    KEY DEVELOPMENTS

LIST OF TABLES    

TABLE 1    EADING COMPANIES IN THE MHEALTH MARKET

TABLE 2         SECURITY BREACHMENT CASES/ DEVELOPMENTS (2011-2015)

TABLE 3        MHEALTH INDUSTRY: KEY PARTNERSHIPS

TABLE 4        VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM

TABLE 5        CONSORTIUMS IN MHEALTH MARKET

TABLE 6        ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET

TABLE 7        REGULATORY BODIES IN MHEALTH MARKET

TABLE 8        MHEALTH MARKET CERTIFICATIONS

TABLE 9        FACTORS IMPACTING THE BUYER’S BARGAINING POWER

TABLE 10    FACTORS IMPACTING THE SUPPLIER’S BARGAINING POWER

TABLE 11    FACTORS IMPACTING THE THREAT FROM SUBSTITUTE

TABLE 12    FACTORS IMPACTING THE THREAT FROM NEW ENTRANT

TABLE 13    FACTORS IMPACTING THE DEGREE OF COMPETETION

TABLE 14    GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)

TABLE 15    GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2014-2022 ($MILLION)

TABLE 16    GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)

TABLE 17    GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2014-2022 ($MILLION)

TABLE 18    GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)

TABLE 19    KEY DEVELOPMENTS

TABLE 20    NETWORK & SERVICES: KEY DEVELOPMENTS

TABLE 21    PHARMACEUTICALS SERVICE: KEY DEVELOPMENT

TABLE 22    GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 23    CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 24    CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 25    TYPE OF APP

TABLE 26    KEY DEVELOPMENTS

TABLE 27    DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 28    DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 29    KEY DEVELOPMENTS

TABLE 30    RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 31    RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 32    NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 33    NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 34    FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 35    FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 36    OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 37    OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 38    GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 39    MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)

TABLE 40    MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 41    MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 42    REMOTE MONITORING IN GEOGRAPHIES

TABLE 43    DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)

TABLE 44    DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 45    DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 46    DIAGNOSIS AND TREATMENT IN GEOGRAPHIES

TABLE 47    EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)

TABLE 48    EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 49    EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 50    EDUCATION & WELLNESS IN GEOGRAPHIES

TABLE 51    HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)

TABLE 52    HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 53    HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 54    HEALTHCARE MANAGEMENT IN GEOGRAPHIES

TABLE 55    WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)

TABLE 56    WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 57    WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 58    WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES

TABLE 59    OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)

TABLE 60    OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 61    OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 62    MHEALTH: KEY DEVELOPMENTS (2011- 2015)

TABLE 63    GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 64    THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION)

TABLE 65    THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 66    THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 67    THE U.S.: KEY DEVELOPMENTS

TABLE 68    SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2011-2015)

TABLE 69    APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 70    APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 71    KEY DEVELOPMENTS IN APAC

TABLE 72    EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 73    EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 74    EUROPE: MHEALTH MARKET DEVELOPMENT

TABLE 75    ROW: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION)

TABLE 76    ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)

TABLE 77    ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 78    AFRICA: MHEALTH MARKET DEVELOPMENTS (2011-2014)

TABLE 79    MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2014-2011)

LIST OF FIGURES    

FIGURE 1    MHEALTH MARKET STUDY: COVERAGE AREA

FIGURE 2    XX RESEARCH METHODOLOGY

FIGURE 3    DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET

FIGURE 4    MHEALTH MARKET: RESEARCH METHODOLOGY

FIGURE 5    GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2014-2022 ($MILLION)

FIGURE 6    GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2014-2022 ($MILLION)

FIGURE 7    GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2022 ($MILLION)

FIGURE 8    GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

FIGURE 9    MARKET DRIVERS AND CHALLENGES

FIGURE 10    MHEALTH MARKET DRIVERS: IMPACT ANALYSIS

FIGURE 11    BENEFITS OF MHEALTH TO PATIENTS

FIGURE 12    EXAMPLES OF EXISTING MHEALTH INNOVATIONS

FIGURE 13    MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS

FIGURE 14    MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS

FIGURE 15    VALUE CHAIN

FIGURE 16    ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS

FIGURE 17    CLASSIFICATION OF MEDICAL DEVICES

FIGURE 18    MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS

FIGURE 19    MHEALTH ECOSYSTEM

FIGURE 20    TYPE OF MHEALTH DEVICES

FIGURE 21    SMBD DEVICE USES

FIGURE 22    USES OF BP MONITORING DEVICE

FIGURE 23    PULSE OXIMETER USES

FIGURE 24    WEARABLE DEVICE COMPONENTS

FIGURE 25    TYPE OF WEARABLE ELECTRONICS DEVICES

FIGURE 26    HAND WORN MHEALTH DEVICES

FIGURE 27    APPLE WATCH FIGURE

FIGURE 28    LEADING FITNESS TRACKING WRIST BANDS

FIGURE 29    GOOGLE’S CONTACT LENS

FIGURE 30    HEAD WORN DEVICES

FIGURE 31    ELECTRONIC FINGERTIP

FIGURE 32    COMPONENTS OF BIOSTAMP

FIGURE 33    MYO ARMBAND BY THALMIC LABS

FIGURE 34    NON-CLINICAL BENEFITS

FIGURE 35    WEARABLE MEDICAL DEVICES

FIGURE 36    FITNESS TRACKING DEVICES

FIGURE 37    TYPES OF MHEALTH SERVICES

FIGURE 38    TYPES OF APPS

FIGURE 39    BENEFITS OF BIG DATA

FIGURE 40    BENEFITS OF NETWORK & SERVICES

FIGURE 41    ROLES OF MOBILE OPERATORS

FIGURE 42    ROLE OF HEALTHCARE PROVIDERS

FIGURE 43    MHEALTH: MARKET BY THERAPEUTICS

FIGURE 44    BENEFITS OF MHEALTH IN CVDS

FIGURE 45    BENEFITS OF MHEALTH

FIGURE 46    BENEFITS OF MHEALTH

FIGURE 47    BENEFITS OF MHEALTH

FIGURE 48    BENEFITS OF MHEALTH

FIGURE 49    TYPES OF MHEALTH APPLICATION

FIGURE 50    ADVANTAGES OF REMOTE MONITORING

FIGURE 51    DIAGNOSIS AND TREATMENT SERVICES

FIGURE 52    EDUCATION & AWARENESS SERVICES

FIGURE 53    MHEALTH HEALTHCARE MANAGEMENT

FIGURE 54    GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY

FIGURE 55    APAC: MARKET DRIVERS

FIGURE 56    MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2015)

FIGURE 57    MHEALTH: MERGERS & ACQUISITIONS (2015)

FIGURE 58    MHEALTH: KEY PRODUCT LAUNCH & DEVELOPMENTS (2015)

FIGURE 59    MHEALTH: KEY BUSINESS EXPANSIONS & CONTRACTS (2015)

FIGURE 60    MHEALTH: KEY PATENTS/APPROVALS (2015)

FIGURE 61    APPLE INC. OVERALL FINANCIALS ($BILLION), 2012-2014

FIGURE 62    APPLE INC.: NET REVENUE, BY SEGMENT, 2012-2014

FIGURE 63    APPLE INC.: NET REVENUE, BY REGION, 2012-2014

FIGURE 64    ATHENAHEALTH: OVERALL FINANCIALS, 2012-2014 ($MILLION)

FIGURE 65    ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION)

FIGURE 66    AT&T INC.: OVERALL FINANCIALS ($BILLION), 2012-2014

FIGURE 67    AT&T INC.: NET REVENUE BY SEGMENT, 2012-2014

FIGURE 68    BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2012-2014

FIGURE 69    BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014

FIGURE 70    GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2012-2014

FIGURE 71    GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014

FIGURE 72    GE HEALTHCARE SEGMENT, 2014

FIGURE 73    GOOGLE: OVERALL FINANCIALS, 2012 - 2014 ($BILLION)

FIGURE 74    J&J: OVERALL FINANCIALS, 2012 - 2014 ($ BILLION)

FIGURE 75    LABCORP OVERALL FINANCIALS ($MILLION), 2012-2014

FIGURE 76    NET REVENUE BY SEGMENTS, 2012-2014

FIGURE 77    NIKE: OVERALL FINANCIALS 2012 - 2014 ($BILLION)

FIGURE 78    NIKE: REVENUE BY REGION (2012-2013)

FIGURE 79    PFIZER: OVERALL FINANCIALS, 2012-2014 ($BILLION)

FIGURE 80    PFIZER: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION)

FIGURE 81    PFIZER: FINANCIALS BY REGION, 2012-2013 ($BILLION)

FIGURE 82    PHILIPS: OVERALL FINANCIALS, 2012-2014 ($MILLION)

FIGURE 83    PHILIPS: FINANCIALS BY REGION, 2012-2014 ($MILLION)

FIGURE 84    PHILIPS: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION)

FIGURE 85    QUALCOMM INC.: OVERALL FINANCIALS, 2012-2014 ($BILLION)

FIGURE 86    QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION)

FIGURE 87    QUALCOMM INC.: NET REVENUE, BY REGION, 2012-2014 ($MILLION)

FIGURE 88    QUEST: OVERALL FINANCIALS, 2012-2014 ($MILLION)

FIGURE 89    QUEST: NET REVENUE BY SEGMENTS, 2013-2014 ($MILLION)

FIGURE 90    ROCHE: OVERALL FINANCIALS, 2012-2014 ($BILLION)

FIGURE 91    ROCHE: NET REVENUE, BY SEGMENTS, 2012-2014 ($BILLION)

FIGURE 92    SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION), 2012-2014

FIGURE 93    SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2012-2014

FIGURE 94    SANOFI PHARMA: NET REVENUE BY SEGMENT, 2012-2014

 

captcha
Please enter code
captcha
Please enter code

Purchase this Market Research Report

Add To Cart

Market Research Videos

Related TAGS

Related Report

Related Categories

REPORT YOU MIGHT BE INTERESTED

Contact Us

Email Us at: salesteam@marketresearchfuture.com | Reach Us at: + (646) 845 9349 (US), +44 208 133 9349 (uk)